2021
DOI: 10.1016/j.nephro.2021.09.001
|View full text |Cite
|
Sign up to set email alerts
|

Toxicité rénale des anticancéreux

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 86 publications
0
3
0
Order By: Relevance
“…34 These necrotic tubules may appear alongside the development of progressive kidney disease, characterized by glomerular mesangial sclerosis and tubular degradation. 16 Common brush boundary losses have also been observed in the proximal tubules. In the current study, moderate rates of atypical glomerular structures were also observed.…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…34 These necrotic tubules may appear alongside the development of progressive kidney disease, characterized by glomerular mesangial sclerosis and tubular degradation. 16 Common brush boundary losses have also been observed in the proximal tubules. In the current study, moderate rates of atypical glomerular structures were also observed.…”
Section: Discussionmentioning
confidence: 98%
“…This in turn leads to impaired kidney function. 16 It is therefore essential to protect the kidneys against IR damage.…”
Section: Introductionmentioning
confidence: 99%
“…The pathophysiology and mechanisms underlying this injury are complex and can vary with different drugs. [9][10][11] Cisplatin (CDDP; cis-diamminedichloroplatinum (II)) was the first inorganic platinum anticancer drug to be approved by the FDA and is one of the most common anticancer drugs available clinically. 12 Cisplatin is widely used in the treatment of lung, breast, liver, prostate, and cervical cancers.…”
Section: Introductionmentioning
confidence: 99%